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Abstract: In most countries, the prevalence of depression in care homes 
is substantially higher than among community-dwelling older people. 
Negative media reports and the stigma associated with long-term care 
perpetuates the belief that community care is associated with a better 
quality of life than nursing or residential home care. The aim of this paper 
is to investigate mental health, quality of life and medication use among a 
sample of care home residents and community dwelling older people. 
This cross-sectional study comprised of structured interviews with 75 care 
home residents and 852 community dwelling older adults in a large health 
and social care trust within the U.K. Data were collected using an 
abridged version of the World Mental Health-Composite International 
Diagnostic Interview (WMH-CIDI). Health-related quality of life was 
assessed using the SF-6D, derived from responses to the SF-12, which 
was embedded within the screening section of the WMH-CIDI. Results 
showed a significantly lower level of mental disorders among older 
people in the care home sample. Health-related quality of life results 
indicated that although care home participants were significantly more 
limited in their physical functioning, they reported better mental health 
and social functioning than older people living in the community. These 
results were statistically significant. Prescription rates for mental health 
medication were higher in the care home sample. This study provides 
tentative findings about mental health and quality of life in care homes, 
which should be further explored in future research. The study addresses 
the negative public perception of quality of life in care homes while 
contributing to the debate around the health care implications of ‘ageing 
in place’ for older people. There is a need to address the relationship 
between mental health, quality of life and medication use among older 
people across a range of care settings.  
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Introduction  
The ageing population of the world has given rise to a 
changing philosophy surrounding the provision of health 
and social care from institutional to community-based 
care. This shift is aimed principally at helping people to 
live in their own homes for as long as possible. However, 
the need for residential care is expected to increase due an 
ageing population, changes in family structure and the 
impact of dementia and other age-related conditions. 
While research has focused on the physical well-being of 
older people, the mental health of older people remains a 
relatively under-researched topic. Moreover, little is 
known about the mental health and quality of life of 
older people living in long-term care settings in 
comparison to their community dwelling peers. 
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Ageing and Mental Health  
The relationship between age and mental health has 
been widely researched in the literature. Some studies 
have reported decreased prevalence rates for mental health 
disorders in older age (Scott et al., 2008; Bunting et al., 
2012; Karel et al., 2012; Reynolds et al., 2015). Others 
have reported lifetime and current prevalence rates of 
mental disorders in older people ranging from 1 to 18% 
(Volkert et al., 2013; Reynolds et al., 2015). The World 
Health Organization (WHO, 2015) estimated that over 
20% of adults aged 60 years and over, experience a 
mental or neurological disorder. The most common 
neuropsychiatric disorders in this age group are 
depression (7%); dementia (5%) anxiety disorders which 
affect 3.8% and substance use problems which affect 
almost 1% of the older population (WHO, 2015). A 
meta-analysis of mental disorders in older adults in 
Western Countries undertaken by Volkert et al. (2013) 
found the lifetime prevalence of affective disorders was 
16.52%, anxiety disorders 2.63%, substance abuse 
disorders 11.71% and psychosis 4.7% 
Depression is a key mental health issue in later life 
and is associated with physical co-morbidities, lower 
quality of life and disability (Covinsky et al., 2010; 
Naylor et al., 2012). A systematic review and meta-
analysis of 24 studies on the prevalence of depression in 
later life (75 years and older) found that the prevalence of 
major depression ranged from 4.6% to 9.3% and that of 
depressive disorders from 4.5% to 37.4%. (Luppa et al., 
2012). According to the Royal College of Psychiatrists 
(RCPsych), depression may affect one in five older 
people living in the community and two in five older 
people living in care homes (RCP, 2014). A cross-
sectional study of community dwelling people aged 60 
years or older in Brazil (n = 1563) found that nearly 
3.8% to 15% of participants presented with depressive 
symptoms (Barcelos-Ferreira et al., 2013). A 
systematic review by Seitz et al. (2010) on the 
prevalence of psychiatric disorders in nursing homes 
reported prevalence rates for depression ranging from 
4% to 25% for major depressive disorder and 29% to 
82% for minor depression or the presence of depressive 
symptoms. A Dutch study exploring the incidence of 
depression in a sample of nursing (n = 1324) and 
residential (n = 1,723) home residents reported that the 
incident rate was 13.6 per100-person years in the 
nursing home and 10.2 per 100-person years in the 
residential home (Boorsma et al., 2012). 
Psychotropic Medication Use 
The use of psychotropic drugs in European care 
homes is reported to be common, with prescription rates 
of psychotropic drugs higher in institutionalized older 
population than that of community dwelling older people 
(Azermai et al., 2011; Haasum et al., 2012). Moreover, it 
has been determined that the prescription rate of 
psychotropic medication is on the increase in care homes 
(Ruths et al., 2013). Psychotropic agents including 
antipsychotics, antidepressants and/or anxiolytics are often 
prescribed as the first-choice treatment option for mental 
health conditions including sleep disturbance, anxiety, 
depression even though professional guidelines advocate 
non-pharmacological management of symptoms     
(Pitkala et al., 2015; Zuidema et al., 2015). Underuse as 
well as overuse of psychotropic medication have also been 
reported in this population (Hanlon et al., 2011). 
Moreover, a recent study on the use of psychotropic 
medications in care homes identified potential benefits of 
antipsychotic medication reduction (Simmons, 2017).  
An evaluation of the quality of antidepressant 
management and prescribing patterns in nursing homes 
in the USA showed a discrepancy between prescriptions 
of antidepressants and the presence or absence of 
depression diagnosis. A review of 205 medical charts 
indicated that for those with documented depression 
diagnoses (n = 126), nearly one quarter were not 
prescribed antidepressants. Moreover, out of 79 medical 
chart reviews indicating no depression diagnosis, nearly 
a third were receiving an antidepressant (Shah et al., 
2011). Another American study of nursing home 
residents identified that second-generation antipsychotics 
were commonly used for off-label indications, including 
treatment of bipolar disorder, depression and psychotic 
symptoms; and these indications were not always 
evidence-based (Kamble et al., 2010). In the United 
Kingdom, it is estimated that approximately 21% of care 
home residents are receiving antipsychotic medications 
and that more than 80% of this prescribing is for 
residents without a diagnosis of severe mental illness 
(Shah et al., 2011). Significantly, Harrison et al. (2018) 
found that an increased number of psychotropic 
medications were associated with lower quality of life 
scores. Furthermore, due to ageing co-morbidities and 
the need for the prescription of multiple medications, 
older people may experience adverse drug effects, drug 
interactions, forgetfulness, lack of familial and social 
support and care and may not be fully concordant with 
taking long term medications. Tsai et al. (2012) stated 
that in general only 50% of the general population has 
been estimated to adhere to their medications and this 
may range from 47 to 100% in older people. In 
addition, medication concordance has been positively 
correlated with educational status and individual’s 
awareness of diseases and prescribed medications 
(Shruthi et al., 2016). 
Quality of Life (QoL)  
There is no standard definition of QoL and 
conceptualizations of QoL vary considerably (Dichter et al., 
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2013). The WHO defines QoL as “individual’s 
perception of their position in life in the context of the 
culture and value systems in which they live and in 
relation to their goals, expectations, standards and 
concerns” (WHO, 1997, p. 1). Several studies have 
investigated which QoL domains older people deem as 
having high importance. Results have identified a broad 
range of QoL priorities including health, activities of 
daily living, sensory abilities and mobility (Kalfos and 
Halvorsrud, 2009; Molzahn et al., 2011); the home 
environment and family (Beaumont and Kenealy, 2004; 
Bowers et al., 2009; James et al., 2014) and finances 
and social life (Evans et al., 2005). Furthermore, 
Bradshaw et al. (2012) identified four key factors 
influencing QoL in care homes; the person's acceptance 
and adaptation to their living situation, their 
‘connectedness’ with others, living in ‘a homelike 
environment’ and carers displaying ‘caring practices’ 
Similar themes emerged from the study by Bowling et al. 
(2013) who identified psychological well-being and a 
positive outlook, having health and functioning, social 
relationships, leisure activities, neighbourhood 
resources, adequate financial circumstances and 
independence as key indicators of QoL in old age. 
The Northern Ireland Study of Health and Stress 
(NISHS) (Bunting et al., 2012) was part of a series of 
epidemiological studies of mental health, conducted in 
over 30 countries throughout the world under the 
auspices of the World Health Organisation (WHO). 
Results indicated that lifetime prevalence rates for mood 
and anxiety disorders increased with age, dropping 
substantially for the 65+ group. Epidemiological studies 
of mental health have largely ignored the growing 
population of older people in residential and nursing 
homes, so it is difficult to determine the extent to which 
their mental health needs are met. Despite current 
demographic trends and the dearth of reliable 
information about the extent and impact of mental health 
problems among care home residents, this group was 
excluded from the NISHS and from all studies involved 
in the WHO initiative. From the authors’ perspectives, 
this constituted a ‘missed opportunity’ and provided the 
impetus for the present study which aimed to examine 
mental health, quality of life and medication use among 
a sample of care home residents and community 
dwelling older people.  
Methods  
Participants and Selection Procedure  
This paper reports on the comparison of two samples 
of older people, who were administered the same 
structured survey instrument, the World Mental Health-
Composite International Diagnostic Interview (WMH-
CIDI) (Kessler and Üstun, 2008).  
Community Sample  
The sample of 852 individuals aged 65 and over 
living in the community was drawn from the Northern 
Ireland Study of Health and Stress (NISHS). The 
NISHS (Mc Lafferty et al., 2018) was part of a series 
of World Mental Health Survey Initiative 
epidemiological studies of mental health, conducted in 
over 30 countries throughout the world under the 
auspices of the World Health Organisation (WHO). The 
study was a representative household survey of English 
speakers, aged 18 years and older. Participants were 
selected from a multistage, clustered, area probability 
sample of households. To achieve an equal probability 
sample, a three-stage area sample design was used. 
First, electoral wards were selected from each local 
government district, based on probability 
proportionate to size. Two-census output areas 
(COAs) were then selected per ward and finally a 
sample of 10 dwellings were selected from each COA. 
The total NISHS sample comprised data from 4,340 
adults, including 852 people aged 65 years and over 
that were included in the current study.  
Care Home Sample  
The sample of 75 care home residents was drawn 
from nursing and residential homes in a Health and 
Social Care Trust in a region of the United Kingdom 
(UK). In the initial stages of data collection, 20 care 
homes were randomly selected from a list provided by 
the statutory body responsible for the regulation of 
care homes. To obtain the necessary sampling frame, 
the manager of each selected care home was asked to 
list all residents who met the following selection 
criteria: aged 65 years of age; minimal cognitive 
impairment as defined by the Mini Mental State 
Examination (Folstein et al., 1975) and physically able 
and willing to consent and participate in the study. 
From this population, a number of individuals from 
each care home were selected using proportional 
allocation based on the number of residents who met 
the selection criteria within each home. Sample 
selection was undertaken by two members of the 
research team using Kish tables on care homes listings 
(Kish, 1965). The researcher then met with potential 
participants to provide verbal and written information 
about the study and to answer any questions about the 
study. Residents who wished to take part were then 
asked to sign a consent form for the interview, which 
was arranged at a time and place to suit the resident. The 
initial interviews were recorded and checked to ensure 
the rigor of the data collection procedures. This process 
also determined the acceptability of questions and 
interview duration for care home residents. The selected 
respondents were interviewed by the first author who is 
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an experienced qualitative researcher and mental health 
nurse. The interview responses were recorded on a 
laptop. Interview questions were also presented in a 
respondent booklet (RB) that provided a visual aid as 
the questions were being read by the interviewer. 
Misunderstandings based on vagueness of terms were 
addressed by introducing clarifications and examples. 
The use of such instruction aimed to improve the 
quality of data obtained. 
Instruments  
The World Mental Health-Composite International 
Diagnostic Interview (WMH-CIDI) (Kessler and Üstun, 
2004) was used to collect data. WMH-CIDI is a widely 
used and extensively tested interview schedule used for 
the assessment of mental health disorders. Lay 
interviewees underwent the standard WHO WMH-CIDI 
training program which included 30 hours of at-home 
self-study with a series of manuals and CD-ROMs 
followed by 3-5 days of in-person training by skilled 
CIDI Trainers. A compulsory assessment was 
undertaken at the end of training to award certification 
which was necessary to undertake interviews. CIDI 
training included data collection, editing, coding and 
clearing in addition to study specific interviewing 
techniques and field quality control issues. The CIDI 
interview contains questions on the factors influencing 
mental health including depression, anxiety disorders, 
chronic illness and social networks. The interview 
generates psychiatric diagnoses according to the 
definitions and criteria of both the International 
Statistical Classification of Diseases tenth edition (ICD-
10) (WHO, 1992) and the Diagnostic and Statistical 
Manual of Mental Disorders Fourth Edition (DSM-IV) 
(American Psychiatric Association, 1994). The CIDI 
allows the investigator to measure the prevalence of 
mental disorders; the severity of these disorders in 
addition to assessing medication use and treatment 
interventions. The WMH-CIDI also establishes 
symptoms and age of onset, data which will enable the 
research team to determine whether reported symptoms 
commenced prior to, simultaneous with, or following, 
admission to a care home. Embedded within the WMH-
CIDI are instruments assessing health related quality of 
life and medication use, as well as a range of questions 
relating to socio-demographic characteristics. The 
WMH-CIDI in its entirety takes an average of 
approximately 1.5 to 2 hours to administer. However, the 
interview time varies widely depending on the number of 
diagnostic sections for which the respondent screens 
positive. For this study, face- to face structured 
interviews were undertaken by the principal investigator 
using an abridged electronic CIDI instrument and took 
approximately 1.5 hours to complete. 
Reliability and Validity 
A considerable amount of research has been 
undertaken by researchers to refine the instrument prior 
to the WMH Survey Initiative (Brugha et al., 2001; 
Kessler and Ustun, 2004). The validity of the WMH-
CIDI has been tested to determine whether the diagnoses 
generated by the WMH-CIDI are consistent with those 
obtained independently by trained clinical interviewers 
such as psychiatrists. Results have shown that CIDI 
diagnoses are significantly related to independent 
clinical diagnoses (Kessler and Ustun, 2004).  
SF-12v2 
The Short Form 12 (SF-12) is a shortened form (12 
items) of the SF-36v2 Health Survey. It is a generic 
assessment of health-related quality of life (HR QOL) 
from the client/patient’s perspective. The instrument 
contains 12 questions, addressing eight key domains 
of health related QoL: physical functioning, limitation 
of role due to physical health problems, bodily pain, 
general health vitality, social functioning, role 
limitations due to emotional problems and finally 
general mental health. These eight domains can be 
summarised into a physical component summary 
(PCS) and a mental component summary (MCS. The 
SF-12 was also used to derive a preference based 
index of health related QoL for each individual (a 
quality of life weighting ranging from 0 to 1). A 
scoring algorithm developed by Brazier and Roberts 
(2004) was used to transform SF-12 response levels 
into SF-6D response levels. The SF-6D is also a 
generic health related quality of life (QoL) survey 
which assesses six dimensions of health: physical 
functioning, role limitations, social functioning, pain, 
mental health and vitality.  
Outcome Measures  
The current paper considered four broad outcome 
measures: (1) Lifetime mood and anxiety disorders; (2) 
12-month mental health medication use; (3) overall 
health related quality of life and (4) individual health 
related quality of life domains. The prevalence of any 
lifetime mood or anxiety disorder was determined by 
the percentage of the study sample that met the DSM-
IV criteria for a mood or anxiety disorder at some point 
their lifetime, as assessed by the WMH-CIDI. This 
summary variable was based on the assessment of 13 
mood and anxiety disorders: major depressive episode, 
major depressive disorder, dysthymia, specific phobia, 
social phobia, panic disorder, obsessive-compulsive 
disorder, generalised anxiety disorder, separation 
anxiety disorder, adult separation anxiety disorder, 
agoraphobia with and without panic and post-traumatic 
stress disorder. A dichotomous variable was created to 
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indicate whether an individual met the criteria for any 
of these disorders during their lifetime. All 
participants were asked about medication they had 
taken in the previous 12-months for problems with 
‘emotions, nerves or mental health’ within the 
following broad medication categories: sleeping pills 
or other sedatives, anti-depressants, hypnotics or 
anxiolytics and anti-psychotics. In addition, the care 
home participants consented to provide details of 
medication records since their admission to the care 
home. A dichotomous variable was created to indicate if 
an individual had taken any of these medication types in 
the previous 12 months. 
Health-related quality of life was assessed using the 
SF-6D, derived from responses to the SF-12, which was 
embedded within the screening section of the WMH-
CIDI. A scoring algorithm developed by Brazier and 
Roberts (2004) was used to transform SF-12 response 
levels into SF-6D response levels. The SF-6D is a 
classification system for describing health related quality 
of life comprising six multi-level dimensions: physical 
functioning, role limitations, social functioning, pain, 
mental health and vitality. Response levels for each of 
the dimensions indicate the level of difficulty 
experienced by participants. There are three response 
levels for physical function, four for role limitations and 
five response levels for each of the other four 
dimensions. Higher response levels indicate poorer 
outcomes. An overall health-related quality of life index 
was also derived from SF-6D responses. Population 
based weights, also derived by Brazier and Roberts 
(2004), were applied to responses to determine each 
individual’s health-related quality of life weighting 
(from 0-1). The resulting index describes a potential 
18,000 health states in all, with higher scores indicating 
better overall health-related quality of life.  
Data Analysis 
Statistical algorithms, developed in Harvard for use 
in all WMH surveys, were applied to the final dataset to 
generate a series of DSM-IV (APA, 1994) dichotomous 
diagnostic variables for mental health disorders. Lifetime 
prevalence of any mood or anxiety disorder was 
determined by calculating the percentage of participants 
who met the criteria for each any of the 13 mood or 
anxiety disorders, detailed previously at any point in 
their lifetime. Descriptive statistics were used to estimate 
lifetime mood or anxiety disorders, medication use, 
average overall health-related quality of life scores and 
dimension scores. Independent samples t-tests and chi-
squared tests were used to compare outcomes between 
community dwelling and care home residents. Linear 
regression analyses (Hosmer and Lemeshow, 1989) were 
used to examine the association of sex, setting 
(community versus care home) and age with any lifetime 
mood or anxiety disorder. Logistic regression was 
similarly used to examine the association of these 
variables with any 12-month medication use for 
problems with ‘emotions, nerves or mental health’. Odds 
ratios indicated the strength of these associations and 
statistical significance was evaluated using 2-sided, 
design-based P.05-level tests. The study examined the 
association of sex, setting and age with overall health-
related quality of life (SF-6D score) using linear 
regression. Where assumptions of equal variance are 
violated, tests that deal with unequal variances (e.g. 
Welch’s test for unequal variance) were used. 
Results 
Profile of Participants 
Of the 927 participants aged 65 years and over, 411 
(44.3%) were males and 516 females (55.7%). There were 
852 (91.9%) living in the community and 75 (8.1%) living 
in care homes. The male/female breakdown varied across 
the two settings, with a 46.2/53.8% male/female 
breakdown in the community sample and 22.7/77.3% 
breakdown in the care home sample. 
Prevalence of Any Lifetime Mental Health Disorder 
and Use of Mental Health Medication  
DSM-IV disorders were lowest amongst the 65+ year 
age group, (22.2%) community care sample in 
comparison to (12%) in the care home sample. Results 
show a significant difference in the prevalence of any 
lifetime mental health disorder between the two samples, 
with a much higher level among the community sample 
(X2 = 9.93, 1 df, p = 0.002). While 18.0% of individuals 
living in the community met the criteria for any lifetime 
mood or anxiety disorder, just 3.0% of those in care 
homes had a lifetime disorder. panic disorder and panic 
attacks compared to 2.8% reporting lifetime panic 
disorder in the NISHS. The lifetime prevalence of Post- 
traumatic Stress Disorder (PTSD), (6.0%) and specific 
phobia, (SP) (5.6%) were higher among the NISHS 
sample compared to the care home sample (PTSD 1.3% 
(n = 1) and Specific Phobia 2.6% n = 2). A similar 
picture emerged for lifetime major depressive disorder 
which was prevalent among 2.6% (n = 2) of the care 
home sample compared to 8.1% of the NISHS sample. 
Results indicate that overall there was a very low 
prevalence of DSM disorders among the care home 
sample. CIDI data to show participants who had met the 
DSM diagnostic criteria for mental health disorders are 
outlined in Table 1. 
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Table 1: Lifetime prevalence of DSM-IV disorders 
Disorder  Community % Care Home % 
Anxiety disorders 
Panic disorder 1.8 2.6 
Panic attacks Not measured 2.6 
GAD without hierarchy 2.8 0.0 
Social phobia 2.1 0.0 
Specific phobia 5.6 2.6 
Agoraphobia without panic 0.9 0.0 
Post-traumatic stress disorder 6.0 1.3 
Obsessive compulsive disorder 0.0 0.0 
SAD/ASA 2.0 0.0 
Any anxiety 16.1 0.0 
Mood disorders MDD with hierarchy 8.1 2.6 
Dysthymia with hierarchy 0.9 0.0 
Bipolar-broad 0.4 0.0 
Any mood 9.0 0.0 
Impulse-control disorders 
ODD with hierarchy 0.5 0.0 
Conduct disorder 0.2 0.0 
ADHD 0.4 0.0 
IED with hierarchy 1.2 0.0 
Any impulse 1.9 0.0 
Substance disorders 
Alcohol abuse w/without dependence 3.6 0.0 
Alcohol dependence with abuse 1.2 0.0 
Drug abuse w/without dependence/Abuse 0.0 0.0 
Any substance 3.6 0.0 
Any disorder 22.2 12.0 
GAD, Generalized anxiety disorder; SAD/ASA, separation anxiety disorder/adult separation anxiety; MDD, major depressive 
disorder; ODD, oppositional-defiant disorder; ADHD, attention-deficit hyperactivity disorder; IED, intermittent explosive disorder. 
 
Table 2: Comparison of 12-month mental health medication use among community and care home dwellers  
 Community sample % (n) Care home sample % (n) 
Sleeping pills or other sedatives† 9.0 (77) 41.8 (28) 
Antidepressants† 5.4 (46) 28.4 (19) 
Hypnotics/Anxiolytics† 4.0 (34) 20.9 (14) 
Anti-psychotics† 0.1 (1) 6.0 (4) 
Any Mental Health Medication† 14.7 (125) 64.2 (43)  
†Indicates significant differences between community and care home dwellers at the 5% level 
 
Table 2 summarises the percentage of individuals 
who were taking specific medication types and shows 
that, despite low levels of mental disorders among the 
care home sample, medication prescription levels 
were considerably higher than those recorded for 
community dwelling older adults. Table 2 shows that 
41.8% of the care home sample had taken sleeping 
pills or other sedatives in the previous 12 months 
compared to 9.0% of those over 65 years old living in 
the community. Displaying a similar trend, 28.4% of 
the care home sample were on anti-depressant 
medication in the previous 12-months compared to 
5.4% of the community sample. Almost 21% of those 
living in care homes had taken hypnotics or 
anxiolytics in the previous 12 months compared to 
4.0% of older adults in the community. Finally, a 
higher percentage of care home residents had taken 
anti-psychotic medication compared to those in the 
community (6.0% compared to 0.1%). These findings 
are noteworthy insofar as it appears to run contrary to 
the results presented earlier in the paper, which 
showed lower levels of mental disorders among care 
home residents compared to older adults within the 
general population.  
Considering all four mental health medication types, 
a comparison of the percentage of individuals that took 
any mental health medication in the previous 12 months 
for mental health problems again shows significant 
differences between the care home and community 
sample. Chi-square tests show that those living in care 
homes were significantly more likely to have taken 
medication for mental health problems in the previous 12 
months (X2 = 101.912, 1 df, p = 0.000). Within the 
community 14.7% of individuals reported that they had 
taken a mental health medication in the previous 12 
months compared to 64.2% in the care home sample. 
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Association of Setting, Gender and Age with Mental 
Health and Medication  
Logistic regression analyses were used to examine 
the association of setting, sex and age with any DSM-
IV lifetime disorder and the use of any mental health 
medication in the previous 12 months (Table 3).  
While individuals living in care homes were 
significantly less likely to meet the criteria for a 
lifetime mental health disorder, they were significantly 
more likely to have taken mental health medication in 
the previous 12 months. Females were more likely than 
males to have a lifetime mental health disorder and 
more likely to have taken a mental health medication.  
Older individuals were less likely to have a lifetime 
mental disorder, while there was no association 
between age and mental health medication. 
Comparison of SF12 Scores 
The SF-12 was scored so that a high score indicates 
better functioning. The Physical Component Summary 
(PCS) and the Mental Component Summary (MCS) 
scores have a range of 0 to 100 and are designed to 
have a mean score of 50 and a standard deviation of 10. 
Thus, scores greater than 50 represent above average 
health status. Response levels for each of the six 
dimensions are described in the methods section, but to 
summarise, higher response levels indicate poorer 
outcomes for each of the dimensions. 
Table 4 presents the results from an independent 
samples t-test, assuming unequal variances, found a 
significant difference in of health-related quality of life, 
with higher scores indicating worse outcomes, 
individuals living in care homes had significantly poorer 
physical functioning (p = 0.000) and were more limited 
in their daily roles (p = 0.044) compared to those living 
in the community. Conversely, those living in care 
homes had better outcomes relating to social functioning 
(p = 0.000), pain (p = 0.001) and mental health (p = 
0.001). There were no significant differences in relation 
to vitality between the two sub-samples overall health 
related quality of life (p = 0.028) and in all dimensions 
of health-related quality of life, except for ‘vitality’. 
Overall, health-related quality of life was poorer among 
the sample of individuals living in care homes. 
Considering each of the 6 dimensions. 
Overall the total SF12 scores were statistically 
different across the settings with NISHS (65+) having 
lower scores overall. Table 3 shows that NISHS sample 
had an MCS mean score of 54, compared to a mean 
score of 61.6 for the care homes sample. The NISHS had 
a mean PCS score of 43.8, while the mean PCS score for 
the care homes sample was 35. The mean scores for the 
US general population for this age group were 43.5 for 
the PCS and 51.5 for the MCS. 
Multiple regression was conducted to examination of 
the impact of independent variables (gender, age, setting 
and physical health scores) show that the model explains 
7.9% of the variance of mental health scores. Analysis of 
variance scores show the significance of the model in 
predicting mental health F (4,992) = 20.753, p = 0.001). 
Examination of the impact of the four independent 
variables show that as age increased by a year, mental 
health scores increased by 0.12, gender (male to female) -
0.063; setting (at NISHS Vs Care Home) 0.229, mental 
health increased by 0.112 with each one-unit in physical 
health and all at a statistically significant level (p = 0.001). 
Similar analysis was run with physical health show 
that the model explains 7.5% of the variance. Analysis of 
variance scores show the significance of the model in 
predicting physical health F (4,922) = 19.8, p = 0.001). 
Examination of the impact of the four independent 
variables show that as age increased by a year, physical 
health scores decreased by -0.146, gender (male Vs 
female) -0.107, setting (at NISHS Vs Care Home) -
0.159, physical health component increased by 0.112 
with each one-unit in mental health and all relationships 
at a statistically significant level (p = 0.001). 
Further examination of physical health component 
shows that, after controlling for age, only NISHS (65+) 
and the Care Homes had a statistically significant 
difference in mean scores (Table 4). Likewise, with 
mental health component, mean scores were different at 
a statistically significant level however the means scores 
were significantly higher in the NISHS (65+) group. 
 
Table 3: Logistic regression analyses examining association of setting, gender and age with mental health and medication  
 Lifetime disorder  12-month medication use 
 -------------------------------------------------- -------------------------------------------------- 
 Odds ratio (CI) SE Odds ratio (CI) SE 
Setting 
Community  0.00 
Care home 0.212 (0.05, 0.90)† 0.156 8.87 (4.99, 15.77)† 2.59 
Sex 
Male 0.00 
Female 2.24 (1.54, 3.26)† 0.430 2.18 (1.49, 3.20)† 0.434 
Age 0.91 (0.88, 0.94)† 0.016 1.01 (0.98, 1.03) 0.014 
†Indicates significant differences between community and care home dwellers at the 5% level 
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Table 4: Comparison of health-related quality of life among community and care home dwellers 
 NISHS community sample mean (SD) Care home sample mean (SD) 
PCS 43.8 (12.33) 35.1 (10.47) 
MCS 54.02 (8.62) 61.6 (6.91) 
Physical Functioning † 1.58 (0.82) 2.49 (0.78) 
Role Limitations † 1.64 (0.95) 1.84 (0.79) 
Social Functioning † 1.73 (1.13) 1.28 (0.61) 
Pain † 2.18 (1.24) 1.73 (1.10) 
Mental Health † 1.84 (0.99) 1.51 (0.81) 
Vitality 2.74 (1.05) 2.84 (0.86) 
†Indicates significant differences between community and care home dwellers at the 5% level 
Physical Component Summary (PCS)  
Mental Component Summary (MCS) 
 
Table 5: Comparison of SF-6D health related quality of life scores 
  SF6D Total 
Community Mean 0.78 
n = 852 Std. Deviation 0.16 
Care Home  Mean 0.75 
n = 75 Std. Deviation 0.11 
Total Mean 0.78 
n = 927 Std. Deviation 0.15 
Significant level 
Statistical Test  Community Care Home 
Kaiser-Meyer-Olkin  0.853 0.556 
measure of  
sampling adequacy 
Bartlett’s test of Sphericity  1633/15* 76.63/15* 
Variance 45% 39.6% 
Cronbach’s alpha 0.82 0.63 
Mean (Std Dev) 0.78 (0.16) 0.75 (0.11) * 
*There was a statistically significant difference between SF6D scores across settings (t (925) 2.235, P>0.05) 
 
Comparison of SF-6D Health Related Quality of 
Life Scores  
The SF-6D score is a preference-based index of 
overall health-related quality of life ranging from zero 
to one, derived by applying population-based 
preference weights to response levels across six 
dimensions. A higher overall SF6D score indicates 
better health related quality of life. Examination of the 
SF6D psychometric properties with factor analysis 
using maximum likelihood extraction with Promax 
rotation of the SF6D, indicates that a single factor 
structure was present. Kaiser-Meyer-Olkin Measure of 
sampling adequacy was 0.839; Bartlett’s test for 
sphericity (1617, (df = 15) p = 0.00 confirm the 
acceptability of the items for factor analysis. The single 
factor structure accounted for 52% of the variance. 
Cronbach’s alpha scores confirm the uni-
dimensionality of the construct (Alpha = 0.81). 
Therefore, it was appropriate to summate to total level. 
A comparison of the average quality of life scores 
reveals significant differences between the care home 
sample and NISHS sample (Table 5). Further 
examination of the association of setting, sex and age 
with overall health-related quality of life (SF6D score) 
was conducted using linear regression. Results from 
linear regression analysis show that females had 
significantly poorer health-related quality of life than 
males (p = 0.000), controlling for setting and age. 
There were no significant differences in quality of life 
scores with respect to setting and age. Therefore, 
gender was a strong predictor of quality of life scores 
irrespective of age or setting. 
Discussion 
This study examined mental health, quality of life 
and psychotropic medication use among 75 care home 
residents and 852 of community dwelling older people. 
Consistent with other studies (Kessler et al., 2010; 
O’Connor and Parslow, 2010, McEvoy et al., 2011, 
Bunting et al., 2012), results from both samples 
showed a low prevalence of mental disorders among 
older adults, in comparison to middle-aged and young 
adults. While there is evidence to suggest that mental 
disorders are prevalent among nursing home residents 
(Fullerton et al. (2009); Grabowski et al., 2010), this 
was not supported in this study. While 18.0% of 
individuals over 65 years living in the community met 
the criteria for any lifetime mood or anxiety disorder, 
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just 3.0% of those in care homes had a lifetime 
disorder. This is discussed within limitations. 
In the context of the age and gender difference 
between both cohorts, it was found that females were 
more likely than males to have a mental disorder and 
older individuals were less likely to have a lifetime 
mental disorder. This is in keeping with worldwide 
studies suggesting that while mental health disorders 
are less prevalent among older age groups, there is a 
higher prevalence amongst women. An American 
National Comorbidity Survey undertaken by Byers et al. 
(2010) found that the likelihood of having a mood, 
anxiety, or combined mood-anxiety disorder generally 
showed a pattern of decline with age (P < 0.05). Some 
evidence from European studies report that for men, 
depressive mood relates to chronic ill health and for 
women, the differences are more closely associated 
with social factors, such as isolation, contact with 
family and belonging to faith or other community 
groups (Grundy et al., 2013). Evidence from the United 
Kingdom points to increasing incidence of depression 
for men older than 75 years and for women older than 
65 years (McCrone et al., 2008). In a Korean study, 
Kim and Park (2012) found a significant gender 
difference in the proportion of older men and women 
with depression. Consistent with the findings of the 
present study Carayanni et al. (2012) in an urban Greek 
population found that women had a higher prevalence 
of depression than men did.  
Mental health and quality of life are inextricably 
linked and this is supported by the results of the present 
study. Even though health-related quality of life was 
poorer among the sample of individuals living in care 
homes and they had significantly poorer physical 
functioning, participants reported better social 
functioning, less pain and better mental health than their 
community dwelling counterparts. These findings are 
supported by a cross-sectional survey undertaken by 
Xiao et al. (2016) who explored the relationships 
between Health-Related Quality of Life (HRQoL), 
depression and living arrangements among older adults 
living in both the community (n = 220) and nursing 
homes (n = 231). Results indicated that the older adults’ 
living arrangement did not directly influence their 
HRQoL but had indirect effects through activities of 
daily living (ADLs) and depression. This suggests that 
living in nursing homes does not directly cause older 
adults’ poor HRQoL, but poor ADLs and more severe 
depression among nursing home residents is likely to 
lead to poor HRQoL.  
While individuals living in care homes were 
significantly less likely to meet the criteria for a lifetime 
mental health disorder, they were significantly more 
likely to have taken mental health medication in the 
previous 12 months. Females were more likely than 
males to have taken a mental health medication; 
however, there was no association between age and 
mental health medication. Despite the low prevalence of 
mental disorders reported in the present study, it is 
significant that over a third (37.3%) (n = 28) of the care 
home residents were being treated for depression. 
Although this figure is consistent with that of Harris 
(2012) who found that 37.5 per cent of nursing home 
residents were prescribed antidepressants, it nonetheless 
suggests a serious disconnect between diagnosis and 
prescribed treatment.  
It is widely acknowledged that diagnosing depression 
can be difficult as many of the symptoms (e.g., fatigue, 
insomnia and reduced appetite) may also be related to 
other physical health problems (Nicol, 2011). There is 
also evidence to suggest that depression is commonly 
inadequately diagnosed and treated in nursing homes 
(Barca et al., 2009). While this could partially explain 
the disparity, it could also be argued that the anti-
depressants were working and therefore participants did 
not meet the diagnostic criteria for depression. However, 
our study was based on assessment of mental health 
disorders at any point in an individual’s lifetime and 
therefore the use of current anti-depressant medication 
should not have a substantial impact on lifetime 
prevalence figures. Another possible explanation, 
reported elsewhere in the literature, is that mental health 
medication is being employed as a form of chemical 
restraint (Feng et al., 2009; Stafford, 2010). A recent UK 
study found that approximately 21% of care home 
residents were receiving antipsychotic medications, 80% 
of which were prescribed without a diagnosis of mental 
disorder (Shah et al., 2011). This figure is over twice 
that reported in the present study (12%). Moreover, a 
recent national data linkage study undertaken within the 
UK by Maguire et al. (2013) exploring the use of 
psychotropic medications and the transition into care 
homes found a higher use of psychotropic drug use in 
care homes (20.3%) compared to the community (1.1%). 
However, regardless of the variation in statistics, it 
remains the case that some of the care home residents in 
the present study were on antipsychotic medication 
without a CIDI (DSM IV) generated diagnosis of a 
lifetime mood or anxiety disorder.  
The use of psychotropic drugs in European nursing 
homes is reported to be quite frequent (Petek Šter and 
Cedilnik Gorup, 2011; Mann et al., 2013). Moreover, 
anxiety and the use of anxiolytics are frequently reported 
among nursing home residents (Seitz et al., 2010). 
Results from the present study showed that almost twice 
as many care home residents (14.6%) (n = 11) were 
taking anxiolytic medication compared to community 
dwelling older adults (6.5%). Galik and Resnick (2013) 
who found that 12% of nursing residents were taking 
anxiolytic medication support this finding. The high 
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prevalence of psychotropic drug use may indicate that 
the treatment is not in line with current treatment 
recommendation (Helvik et al., 2017) suggesting the 
need for care home staff to monitor the effects and side 
effects of psychotropic drugs among their residents. 
The main conclusions of the experimental work should 
be presented. The contribution of the work to the 
scientific community and its economic implications 
should be emphasized. 
Limitations  
This study has several limitations for readers to 
consider. Firstly, the data from both cohorts was not 
collected concurrently as the NISHS was completed 
before data were collected from the care home sample. 
Additionally, it is recognised that the smaller care home 
sample (n = 75) limited a more in-depth analysis of the 
prevalence of specific mood and anxiety disorders and 
the association of a wider range of chracteristics with 
mental health disorders, medication use and QoL in 
comparison to the larger community dwelling cohort 
(n = 852). However, this provides a rationale for a larger 
future study examining these key issues in care homes 
and, in particular, to explore the paradox of low 
prevalence of mental health disorders but high 
prescription rates of mental health medication.  
Secondly, studies of mood and anxiety disorders 
based on structured and standardised assessment 
instruments such as the Composite International 
Diagnostic Interview (CIDI) are extremely limited 
(Volkert et al., 2013). Epidemiological studies using the 
CIDI interview schedule have consistently reported 
lower prevalence of mental disorders among older adults 
and this is confirmed in the present study. O’Connor and 
Paslow (2010) suggested that older adults might respond 
differently than younger adults to cognitively complex 
items on the CIDI. However, this could be interpreted as 
ageist and was later refuted by research, which 
concluded that significantly lower endorsement of CIDI 
screening items by older adults was not due to age-
related bias in the items (Buchan et al., 2013). 
Thirdly, access to the care home residents was gained 
through the home managers and they may have put 
forward their ‘best’ residents for random selection to 
portray quality of life in nursing homes in a positive 
light. Finally, increasing age is associated with 
increasing frailty and dependence leading to admission 
to care home. Functional impairment is one of the most 
important determinants of dependence in older people. It 
is possible that the care home cohort viewed their new 
life as one that offered security and protection in a way, 
they may not have experienced while living at home. 
The possibility that this may have influenced the 
findings is acknowledged.  
Conclusion 
The population of older adults in long-term care is 
predicted to increase significantly in the near future. 
Current government policy across Europe and beyond 
has seen a shift in emphasis from institutional to 
community support for older people and given the 
choice, most older people prefer to remain at home and 
age in place. This study provides tentative findings to 
suggest that the mental health and quality of life of 
socially isolated community dwelling older people may be 
improved after the move to a care home and this requires 
consideration by health and social care providers. 
Conversely, admission to residential care may result in 
polypharmacy and the administration of psychotropic 
medication without a DSM IV diagnosis. Further research 
is required to explore mental health and quality of life 
among care home residents, with a focus on assessment 
methods and prescription patterns.  
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